MedTrace Logo

French Study In ICU Patients Treated With Tigecycline

NCT00799591 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 156

Last updated 2011-12-19

Study results available
· View outcomes & findings →

Summary

This study will describe clinical outcome and safety data collected prospectively in subjects hospitalized in an intensive care unit (ICU) presenting with an infection for which treatment with tigecycline, alone or in combination, is planned. Data will be collected only from subjects providing informed consent.

Conditions

Interventions

OTHER

Observational study so no intervention in the patient.

Observational study so no intervention in the patient.

Sponsors & Collaborators

  • Wyeth is now a wholly owned subsidiary of Pfizer

    lead INDUSTRY

Principal Investigators

  • Pfizer CT.gov Call Center · Pfizer

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-09-30
Primary Completion
2010-05-31
Completion
2010-05-31

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00799591 on ClinicalTrials.gov